Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04369729 · ClinicalTrials.gov registry record

Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache

A clinical trial of Post-Traumatic Headache, sponsored by Mayo Clinic.

Completed
Registry status
101
Enrollment target
5
Study locations

NCT04369729 is a study of Post-Traumatic Headache that has completed, run by Mayo Clinic. The registered enrollment target is 101 participants, above the 88-participant average among 8 other Post-Traumatic Headache trials with a reported enrollment target (15% higher). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04369729, a study of Post-Traumatic Headache, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
101 participants
Enrollment target
5
Study locations

Study Summary

This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence

Conditions Studied

Study Locations (5)

Arizona

  • Phoenix VA Health Care System - Phoenix
  • Mayo Clinic - Phoenix
  • Mayo Clinic - Scottsdale

Florida

  • Mayo Clinic - Jacksonville

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2020-09-09
Est. Completion 2025-08-31

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04369729

The ClinicalTrials.gov registry entry for NCT04369729 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 88-participant average among 8 other Post-Traumatic Headache trials with a reported enrollment target (15% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Traumatic Headache appearing as the primary indexed condition, and to 0 interventions.

NCT04369729 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04369729 about?

NCT04369729 is a clinical study titled "Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache". This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence

What is the current status of trial NCT04369729?

This trial is currently completed. The enrollment target is 101 participants. The study started on 2020-09-09. Estimated completion is 2025-08-31.

What conditions does trial NCT04369729 study?

This clinical trial studies the following conditions: Post-Traumatic Headache.

Who is sponsoring clinical trial NCT04369729?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04369729 being conducted?

This trial has 5 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-Traumatic Headache

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.